ArticlePathogens (Basel, Switzerland)2025
Description of a Current Outbreak of
Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Detection of localNew microbes and new infections · 2026Article
- Post-pandemic surge ofJournal of clinical microbiology · 2026Article
- The Human Virome in Infectious Diseases: Insights from Chronic and Acute Infections Across Body Sites-A Narrative Review.Microorganisms · 2026Review
- A rare case of lung abscess caused by Mycoplasma pneumoniae in an adult with chronic obstructive pulmonary disease.BMC infectious diseases · 2026Article
- Primary mediastinal mucormycosis presenting with hoarseness: a case report.Journal of medical case reports · 2026Article
- Advancing Real-World Evidence Generation: Growth and Lessons Learned from the Early Years of Cosmos.ACI open · 2026Review
- The impact of tele-stewardship on rural and suburban pediatric ambulatory antibiotic prescribing.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- A multi-epitope vaccine targetingFrontiers in immunology · 2026Article
- Doxycycline for Macrolide-ResistantInfection and drug resistance · 2026Review
- Analysis of influenza A, influenza B andFrontiers in public health · 2026Article
- The impact of the COVID-19 pandemic on the epidemiology, clinical manifestations and molecular characteristics ofFrontiers in immunology · 2026Review
- Reactive infectious mucocutaneous eruption: an increasingly encountered complication during periods of increasedASM case reports · 2025Article
- Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities.Current opinion in infectious diseases · 2025Review
- Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study.European journal of pediatrics · 2025Article
- The Clinical Profile of PediatricMicroorganisms · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the COVID-19 pandemic, a significant decline in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.